Canopy Growth Reports FY 2024 Earnings
The TDR Three Key Takeaways regarding Canopy Growth and CEO David Klein:
- David Klein credits strategic changes for Canopy Growth’s improved financial metrics.
- David Klein discusses U.S. market opportunities for Canopy Growth in TDR interview.
- International growth in Australia marks a milestone for Canopy Growth, TDR notes.
Canopy Growth Corporation (TSX:WEED, NASDAQ: CGC), a Canadian based international cannabis and consumer packaged goods company reported its FY 2024 earnings yesterday. The Q4 FY2024 net revenue increased by 7% year-over-year to $72.8 million, with a 16% rise when excluding divested businesses. The company’s total cost of goods sold decreased by 45%, leading to improved gross margins of 27%. Notable growth areas included Storz & Bickel, with a 43% revenue increase, and Canada medical cannabis, which grew 16%. Operating loss from continuing operations was $229 million, showing a 72% improvement in adjusted EBITDA loss. The company has no significant debt obligations due until March 2026.
Canopy Growth’s Q4 and fiscal 2024 results demonstrate substantial progress and strategic changes, reflecting strong financial performance and operational improvements. CEO David Klein emphasized while giving an exclusive interview on “Trade to Black” interview, “This quarter was about just more proof points that this is the time to really get behind Canopy.” Klein stated, “We have a balance sheet with $200 million worth of cash and no debt due until 2026.”
The potential passage of SAFE Banking legislation could significantly enhance Canopy’s U.S. operations. Klein noted, “I still think we’ll get safe banking… that’s maybe closer to the time when everyone will want to jump in.” Canopy aims for profitable growth over market share in fiscal 2025. “We only sell when we can make a fair return for our investors,” said Klein, indicating a focus on sustainable profitability.
Canopy Growth’s flower portfolio ranges from value to premium products. Improvements in flower quality have driven growth in international markets such as Germany and Australia. “We needed to get that right,” Klein remarked about their high-quality flower offerings. The U.S. presents a promising opportunity for cannabis-infused beverages. “We’re really excited about the opportunity for KUSA to do beverages in the U.S.,” Klein highlighted, pointing to concentrated markets as key to profitability.
The Venty device and dry flower vaporization are driving consumer demand. Klein shared, “The Stores and Bickel story really is around innovation… it’s an amazing device because you get all of the flavor.” With no significant debt obligations until 2026 and a substantial cash balance, Canopy Growth is well-positioned financially. “I’m not really concerned about debt in 2026,” Klein asserted, emphasizing the company’s strong financial footing.
Anthony Varrell Co-host of the “Trade to Black” podcast added, “What stood out to me the most was the international growth… growing at an all-time rate in Australia as per this quarter.” He also noted the consumer shift towards premium products and innovative devices, “I strictly use the Venty for consumption now. All of my other methods I just don’t use anymore.” Anthony further emphasized the strategic focus on high-margin products, “We’ve taken a very explicit view on profitable growth in Canada.”Canopy Growth has made significant progress in the 2024 FY, and we will continue to watch the story closely and share our observations with our readers. Want to be updated on all things Psychedelic, Cannabis, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
